• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类风湿关节炎患者中与髓过氧化物酶特异性抗中性粒细胞胞浆抗体相关的快速进展性肾小球肾炎:三例报告

[Rapidly progressive glomerulonephritis associated with myeloperoxidase specific-antineutrophil cytoplasmic antibody in patients with rheumatoid arthritis : report of three cases].

作者信息

Yoshihara R, Tanaka Y, Shiozawa K, Hayakawa M, Nagao M, Imura S

机构信息

Department of Rheumatology, Kakogawa National Hospital, Hyogo.

出版信息

Ryumachi. 1996 Oct;36(5):762-8.

PMID:8969556
Abstract

The reports on the patients with rheumatoid arthritis (RA) complicated with the myeloperoxidase specific-antineutrophil cytoplasmic antibody (MPO-ANCA) associated glomerulonephritis, whose clinical feature is rapidly progressive glomerulonephritis (RPGN), have been rare. We here report three cases of RPGN with MPO-ANCA in RA patients. Case 1. A 44-year-old woman with RA for 25 years was admitted because of RPGN. The level of MPO-ANCA was markedly high (293 EU) and the histological examination of the kidney showed diffuse crescentic glomerulonephritis. In spite of the intensive immunosuppressive therapy, her renal function did not recover and she underwent hemodialysis (HD). Case 2. A 58-year-old man with RA for 5 years was admitted due to RPGN (MPO-ANCA ; 147 EU, Ccr ; 16 ml/min) with the nephrotic syndrome and fever. The treatment with the immunosuppressive agents and the plasma exchange was partially effective to stop the rapid progression of the disease, but a few months later, his renal function worsened (Ccr 7 ml/min). A recent histological examination of the kidney failed to establish the CrGN because of endstage kidney. Case 3. A 56-year-old woman with RA for the past 10 years was admitted because of RPGN (MPO-ANCA ; 652EU). Intensive therapy could not be performed because of an active duodenal ulcer and markedly impaired renal function (Ccr ; 6 ml/min), and soon she underwent HD. Renal biopsy was not done. These three cases suggest that RPGN can occur in part of RA patients with MPO-ANCA.

摘要

关于类风湿关节炎(RA)合并髓过氧化物酶特异性抗中性粒细胞胞浆抗体(MPO-ANCA)相关肾小球肾炎患者的报道较为罕见,其临床特征为快速进展性肾小球肾炎(RPGN)。我们在此报告3例RA患者合并MPO-ANCA的RPGN病例。病例1. 一名患RA 25年的44岁女性因RPGN入院。MPO-ANCA水平显著升高(293 EU),肾脏组织学检查显示为弥漫性新月体性肾小球肾炎。尽管进行了强化免疫抑制治疗,但其肾功能未恢复,遂接受血液透析(HD)。病例2. 一名患RA 5年的58岁男性因RPGN(MPO-ANCA;147 EU,内生肌酐清除率(Ccr);16 ml/min)合并肾病综合征及发热入院。免疫抑制剂及血浆置换治疗对阻止疾病快速进展有部分疗效,但数月后其肾功能恶化(Ccr 7 ml/min)。近期肾脏组织学检查因肾脏终末期病变未能确诊为新月体性肾小球肾炎(CrGN)。病例3. 一名患RA 10年的56岁女性因RPGN(MPO-ANCA;652 EU)入院。由于活动性十二指肠溃疡及明显受损肾功能(Ccr;6 ml/min),无法进行强化治疗,不久后她接受了HD。未进行肾活检。这3例病例提示,部分合并MPO-ANCA的RA患者可发生RPGN。

相似文献

1
[Rapidly progressive glomerulonephritis associated with myeloperoxidase specific-antineutrophil cytoplasmic antibody in patients with rheumatoid arthritis : report of three cases].类风湿关节炎患者中与髓过氧化物酶特异性抗中性粒细胞胞浆抗体相关的快速进展性肾小球肾炎:三例报告
Ryumachi. 1996 Oct;36(5):762-8.
2
[A case with rheumatoid arthritis complicated with ANCA-associated vasculitis].1例类风湿关节炎合并抗中性粒细胞胞浆抗体相关性血管炎
Ryumachi. 1998 Oct;38(5):741-6.
3
[A case of hepatitis C virus-associated glomerulonephropathy presenting with MPO-ANCA-positive rapidly progressive glomerulonephritis].一例丙型肝炎病毒相关性肾小球肾炎合并髓过氧化物酶抗中性粒细胞胞浆抗体(MPO-ANCA)阳性的急进性肾小球肾炎
Nihon Jinzo Gakkai Shi. 2000 May;42(4):353-8.
4
[A case of MPO ANCA associated glomerulonephritis with interstitial pneumonitis complicated with lung tuberculosis and pericarditis].1例伴有间质性肺炎、合并肺结核及心包炎的MPO-ANCA相关性肾小球肾炎病例
Nihon Jinzo Gakkai Shi. 2000 Oct;42(7):591-6.
5
[A case of silicosis with MPO-ANCA-associated glomerulonephritis and alveolar hemorrhage].一例合并髓过氧化物酶抗中性粒细胞胞浆抗体相关性肾小球肾炎及肺泡出血的矽肺病例
Nihon Jinzo Gakkai Shi. 2001 May;43(4):351-6.
6
MPO-ANCA-positive anti-glomerular basement membrane antibody disease successfully treated by plasma exchange and immunosuppressive therapy.髓过氧化物酶-抗中性粒细胞胞质抗体阳性抗肾小球基底膜抗体病经血浆置换和免疫抑制治疗后成功治愈。
Ren Fail. 2011;33(6):626-31. doi: 10.3109/0886022X.2011.581401. Epub 2011 May 20.
7
[An experience of treatment of double positive myeloperoxidase-antineutrophil cytoplasmic antibodies (MPO-ANCA) and anti-glomerular basement membrane antibodies in Goodpasture's syndrome onset of crescentic glomerulonephritis].[新月体性肾小球肾炎起病的Goodpasture综合征中双阳性髓过氧化物酶-抗中性粒细胞胞浆抗体(MPO-ANCA)和抗肾小球基底膜抗体的治疗经验]
Nihon Jinzo Gakkai Shi. 1998 Nov;40(8):591-6.
8
[Two autopsy cases of ANCA-associated glomerulonephritis manifested after contrast medium use].[两例使用造影剂后出现的抗中性粒细胞胞浆抗体相关性肾小球肾炎尸检病例]
Nihon Jinzo Gakkai Shi. 2004;46(4):365-70.
9
[Case of scleroderma with rapid progressive glomerulonephritis associated with both MPO-ANCA and anti-GBM antibodies].[硬皮病合并快速进展性肾小球肾炎伴MPO-ANCA和抗GBM抗体的病例]
Nihon Jinzo Gakkai Shi. 2008;50(1):64-8.
10
[A case of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) related glomerulonephritis associated with systemic sclerosis treated by steroid pulse therapy: a case report].[1例接受类固醇冲击疗法治疗的与系统性硬化症相关的髓过氧化物酶抗中性粒细胞胞浆抗体(MPO-ANCA)相关性肾小球肾炎:病例报告]
Ryumachi. 2000 Oct;40(5):828-32.

引用本文的文献

1
AP-VAS 2012 case report: two patients with rheumatoid arthritis suspected of relapsed microscopic polyangiitis after initiation of dialysis.AP-VAS 2012病例报告:两名类风湿关节炎患者在开始透析后疑似复发性显微镜下多血管炎。
CEN Case Rep. 2013 Nov;2(2):170-173. doi: 10.1007/s13730-013-0081-2. Epub 2013 Jul 4.
2
MPO-ANCA-associated necrotizing glomerulonephritis in rheumatoid arthritis; a case report and review of literature.类风湿关节炎中与髓过氧化物酶抗中性粒细胞胞浆抗体相关的坏死性肾小球肾炎:一例报告并文献复习
J Nephropathol. 2017 Mar;6(2):58-62. doi: 10.15171/jnp.2017.10. Epub 2016 Oct 27.
3
Myeloperoxidase-antineutrophil cytoplasmic antibody-associated crescentic glomerulonephritis with rheumatoid arthritis: a comparison of patients without rheumatoid arthritis.
髓过氧化物酶-抗中性粒细胞胞质抗体相关性新月体肾炎伴类风湿关节炎:与不伴类风湿关节炎患者的比较。
Clin Exp Nephrol. 2010 Aug;14(4):325-32. doi: 10.1007/s10157-010-0278-z. Epub 2010 Mar 26.